MoneyWorks4Me

CORONA Remedies - Quaterly Results

01 Aug 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 4224.30 millions grew by 21.90 % from Rs. 3465.40 millions.Net Profit recorded in the quarter ended June 2026 rise to 29.53% to Rs. 601.00  millions  compared to R. 464.00 millions in corresponding previous quarter.Operating profit surged to 962.80 millions from the corresponding previous quarter of 718.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 4224.30 3465.40 21.90 4224.30 3465.40 21.90 14031.80 11964.20 17.28
Other Income 31.50 20.20 55.94 31.50 20.20 55.94 106.50 59.30 79.60
PBIDT 962.80 718.00 34.09 962.80 718.00 34.09 3040.90 2459.10 23.66
Interest 26.90 19.90 35.18 26.90 19.90 35.18 69.70 106.00 -34.25
PBDT 935.90 698.10 34.06 935.90 698.10 34.06 2780.20 2353.10 18.15
Depreciation 132.40 89.20 48.43 132.40 89.20 48.43 378.70 371.60 1.91
PBT 803.50 608.90 31.96 803.50 608.90 31.96 2401.50 1981.50 21.20
TAX 202.50 144.90 39.75 202.50 144.90 39.75 553.00 491.00 12.63
Deferred Tax 18.70 1.90 884.21 18.70 1.90 884.21 38.20 43.00 -11.16
PAT 601.00 464.00 29.53 601.00 464.00 29.53 1848.50 1490.50 24.02
Equity 611.60 611.60 0.00 611.60 611.60 0.00 611.60 611.60 0.00
PBIDTM(%) 22.79 20.72 10.00 22.79 20.72 10.00 21.67 20.55 5.44

CORONA Remedies Share Price

2113.55 -30.50 (-1.42%)
17-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1882.50
Dr. Reddys Labs. 1192.00
Cipla 1430.00
Lupin 2259.20
Zydus Lifesciences 1132.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: